Evidence map›Paper›PMID 36674842›Full record

ArticleInternational journal of molecular sciences2023

Proof-of-Concept Method to Study Uncharacterized Methyltransferases Using PRDM15.

Li-Na Zhao, Ernesto Guccione, Philipp Kaldis

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Li-Na ZhaoDepartment of Clinical Sciences, Lund University, P.O. Box 50332, SE-202 13 Malmö, Sweden.ORCID 0000-0001-6552-0929
Ernesto GuccioneDepartment of Oncological Sciences and Pharmacological Sciences, Center for Therapeutics Discovery, Tisch Cancer Institute, Bioinformatics for Next Generation Sequencing (BiNGS) Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Philipp KaldisDepartment of Clinical Sciences, Lund University, P.O. Box 50332, SE-202 13 Malmö, Sweden.ORCID 0000-0002-7247-7591
Lund University · SEIcahn School of Medicine at Mount Sinai · US

Funding

Åke Wibergs Stiftelse Ref. No. M21-0048Crafoord Foundation (Ref. No. 20210516 & Ref. No. 20220582)IngaBritt och Arne Lundbergs Forskningsstiftelse LU2020-0013Strategic Research Area EXODIAB Dnr 2009-1039Swedish Cancer Society Cancerfonden; 21-1566PjSwedish Foundation for Strategic Research Dnr IRC15-0067Swedish Research Council 2021-01331
6 · The paper itself

Abstract

The PRDM family of methyltransferases has been implicated in cellular proliferation and differentiation and is deregulated in human diseases, most notably in cancer. PRDMs are related to the SET domain family of methyltransferases; however, from the 19 PRDMs only a few PRDMs with defined enzymatic activities are known. PRDM15 is an uncharacterized transcriptional regulator, with significant structural disorder and lack of defined small-molecule binding pockets. Many aspects of PRDM15 are yet unknown, including its structure, substrates, reaction mechanism, and its methylation profile. Here, we employ a series of computational approaches for an exploratory investigation of its potential substrates and reaction mechanism. Using the knowledge of PRDM9 and current knowledge of PRDM15 as basis, we tried to identify genuine substrates of PRDM15. We start from histone-based peptides and learn that the native substrates of PRDM15 may be non-histone proteins. In the future, a combination of sequence-based approaches and signature motif analysis may provide new leads. In summary, our results provide new information about the uncharacterized methyltransferase, PRDM15.

Indexed as

MethyltransferasesNeoplasmsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseHistonesHumansMethylationTranscription FactorsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseHistonesMethyltransferasesPRDM15 protein, humanPRDM9 protein, humanTranscription Factorsmethyl transfermethyltransferasePRDM15PRDM15 gene effectPRDM15 substrates

Identifiers

PMID36674842
PMCPMC9861158
OpenAlexW4313898082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.